← Evidence map

ReviewHuman genetics2023

CRISPR/Cas-based gene editing in therapeutic strategies for beta-thalassemia.

Shujun Zeng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

19 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37878144